Brief: Merit Medical’S Wrapsody Wave Trial Exceeds Performance Goals For Arteriovenous Graft Patients

Merit Medical Systems

25/11/2024 14:29

Nov 25 (Reuters) - Merit Medical Systems Inc  MMSI.O :
    * MERIT MEDICAL’S WRAPSODY WAVE TRIAL EXCEEDS PERFORMANCE
GOALS
FOR ARTERIOVENOUS GRAFT (AVERAGE) PATIENTS
    * MERIT MEDICAL SYSTEMS INC - WRAPSODY DEVICE SHOWS 81.4%
EFFICACY
IN WAVE TRIAL
    * MERIT MEDICAL SYSTEMS INC - 95.4% OF AVERAGE PATIENTS FREE
FROM
ADVERSE EVENTS IN WAVE TRIAL
    * MERIT MEDICAL SYSTEMS INC - WRAPSODY DEVICE NOT APPROVED
FOR
COMMERCIAL DISTRIBUTION IN U.S.

Source text:  ID:nGNX9HqrWP 
Further company coverage:  MMSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))